MedTrace Logo

I USE LR in the ED

NCT03807648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200000

Last updated 2020-02-12

No results posted yet for this study

Summary

To study the difference in mortality and major adverse kidney events during and after treatment in the emergency department with intravenous fluids per standard of care at 30 days before and after the system-wide implementation.

Conditions

  • Kidney Injury

Interventions

OTHER

Data Inclusion

Patients in this group will be included in the project

Sponsors & Collaborators

  • Intermountain Health Care, Inc.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2019-12-31
Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03807648 on ClinicalTrials.gov